Pets at Home investor expects little impact from UK veterinary market probe
Pets at Home Group investor Schroder Income Growth Fund said it doesn’t expect ongoing UK antitrust scrutiny of the veterinary sector to cause “substantive adverse outcomes” for the company and that...To view the full article, register now.
Already a subscriber? Click here to view full article